theatre royal (plymouth) limited
theatre royal (plymouth) limited Company Information
Group Structure
View All
Industry
Performing arts
Registered Address
theatre royal, royal parade, plymouth, devon, PL1 2TR
Website
theatreroyal.comtheatre royal (plymouth) limited Estimated Valuation
Pomanda estimates the enterprise value of THEATRE ROYAL (PLYMOUTH) LIMITED at £17.7m based on a Turnover of £17.4m and 1.02x industry multiple (adjusted for size and gross margin).
theatre royal (plymouth) limited Estimated Valuation
Pomanda estimates the enterprise value of THEATRE ROYAL (PLYMOUTH) LIMITED at £0 based on an EBITDA of £-1.2m and a 12.09x industry multiple (adjusted for size and gross margin).
theatre royal (plymouth) limited Estimated Valuation
Pomanda estimates the enterprise value of THEATRE ROYAL (PLYMOUTH) LIMITED at £15.8m based on Net Assets of £13m and 1.22x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Theatre Royal (plymouth) Limited Overview
Theatre Royal (plymouth) Limited is a live company located in plymouth, PL1 2TR with a Companies House number of 01560651. It operates in the performing arts sector, SIC Code 90010. Founded in May 1981, it's largest shareholder is unknown. Theatre Royal (plymouth) Limited is a mature, mid sized company, Pomanda has estimated its turnover at £17.4m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Theatre Royal (plymouth) Limited Health Check
Pomanda's financial health check has awarded Theatre Royal (Plymouth) Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 4 areas for improvement. Company Health Check FAQs
6 Strong
2 Regular
4 Weak
Size
annual sales of £17.4m, make it larger than the average company (£342.8k)
£17.4m - Theatre Royal (plymouth) Limited
£342.8k - Industry AVG
Growth
3 year (CAGR) sales growth of 30%, show it is growing at a faster rate (9.5%)
30% - Theatre Royal (plymouth) Limited
9.5% - Industry AVG
Production
with a gross margin of 31.2%, this company has a comparable cost of product (31.2%)
31.2% - Theatre Royal (plymouth) Limited
31.2% - Industry AVG
Profitability
an operating margin of -10.8% make it less profitable than the average company (1.1%)
-10.8% - Theatre Royal (plymouth) Limited
1.1% - Industry AVG
Employees
with 272 employees, this is above the industry average (7)
272 - Theatre Royal (plymouth) Limited
7 - Industry AVG
Pay Structure
on an average salary of £21.3k, the company has a lower pay structure (£27k)
£21.3k - Theatre Royal (plymouth) Limited
£27k - Industry AVG
Efficiency
resulting in sales per employee of £63.9k, this is equally as efficient (£72.9k)
£63.9k - Theatre Royal (plymouth) Limited
£72.9k - Industry AVG
Debtor Days
it gets paid by customers after 5 days, this is earlier than average (8 days)
5 days - Theatre Royal (plymouth) Limited
8 days - Industry AVG
Creditor Days
its suppliers are paid after 12 days, this is quicker than average (15 days)
12 days - Theatre Royal (plymouth) Limited
15 days - Industry AVG
Stock Days
it holds stock equivalent to 3 days, this is less than average (5 days)
3 days - Theatre Royal (plymouth) Limited
5 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 63 weeks, this is less cash available to meet short term requirements (122 weeks)
63 weeks - Theatre Royal (plymouth) Limited
122 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 36.1%, this is a higher level of debt than the average (23.1%)
36.1% - Theatre Royal (plymouth) Limited
23.1% - Industry AVG
THEATRE ROYAL (PLYMOUTH) LIMITED financials
Theatre Royal (Plymouth) Limited's latest turnover from March 2024 is £17.4 million and the company has net assets of £13 million. According to their latest financial statements, Theatre Royal (Plymouth) Limited has 272 employees and maintains cash reserves of £8.4 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 17,369,000 | 16,741,000 | 10,371,000 | 7,851,000 | 16,658,000 | 17,617,000 | 14,168,000 | 17,011,000 | 16,770,000 | 13,862,000 | 22,789,000 | 18,474,000 | 17,689,000 | 17,107,000 | 17,264,000 |
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | 6,002,000 | ||||||||||||||
| Interest Payable | 142,000 | 79,000 | 87,000 | 71,000 | |||||||||||
| Interest Receivable | 20,000 | 45,000 | |||||||||||||
| Pre-Tax Profit | -1,422,000 | -772,000 | -273,000 | 233,000 | -546,000 | -218,000 | 67,000 | -271,000 | 381,000 | -1,379,000 | 6,047,000 | 699,000 | 854,000 | 255,000 | 183,000 |
| Tax | |||||||||||||||
| Profit After Tax | -1,422,000 | -772,000 | -273,000 | 233,000 | -546,000 | -218,000 | 67,000 | -271,000 | 381,000 | -1,379,000 | 6,047,000 | 699,000 | 854,000 | 255,000 | 183,000 |
| Dividends Paid | |||||||||||||||
| Retained Profit | -1,422,000 | -772,000 | -273,000 | 233,000 | -546,000 | -218,000 | 67,000 | -271,000 | 381,000 | -1,379,000 | 6,047,000 | 699,000 | 854,000 | 255,000 | 183,000 |
| Employee Costs | 5,799,000 | 5,147,000 | 4,504,000 | 4,384,000 | 5,426,000 | 5,154,000 | 4,523,000 | 4,671,000 | 4,401,000 | 4,260,000 | 5,028,000 | 5,010,000 | 5,763,000 | 5,763,000 | 5,742,000 |
| Number Of Employees | 272 | 270 | 246 | 310 | 305 | 173 | 165 | 176 | 170 | 158 | 201 | 117 | 129 | 174 | 174 |
| EBITDA* | 6,613,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 10,548,000 | 10,683,000 | 11,656,000 | 11,792,000 | 12,330,000 | 12,561,000 | 12,873,000 | 13,230,000 | 13,912,000 | 14,857,000 | 15,351,000 | 8,806,000 | 8,717,000 | 9,230,000 | 9,690,000 |
| Intangible Assets | |||||||||||||||
| Investments & Other | 502,000 | 523,000 | |||||||||||||
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | 11,050,000 | 11,206,000 | 11,656,000 | 11,792,000 | 12,330,000 | 12,561,000 | 12,873,000 | 13,230,000 | 13,912,000 | 14,857,000 | 15,351,000 | 8,806,000 | 8,717,000 | 9,230,000 | 9,690,000 |
| Stock & work in progress | 101,000 | 97,000 | 96,000 | 43,000 | 68,000 | 55,000 | 54,000 | 56,000 | 44,000 | 45,000 | 60,000 | 58,000 | 74,000 | 68,000 | 104,000 |
| Trade Debtors | 260,000 | 136,000 | 220,000 | 147,000 | 178,000 | 209,000 | 204,000 | 873,000 | 223,000 | 169,000 | 773,000 | 201,000 | 393,000 | 314,000 | 444,000 |
| Group Debtors | |||||||||||||||
| Misc Debtors | 537,000 | 195,000 | 213,000 | 213,000 | 85,000 | 256,000 | 157,000 | 415,000 | 97,000 | 301,000 | 122,000 | 476,000 | 199,000 | 241,000 | 310,000 |
| Cash | 8,381,000 | 8,809,000 | 10,018,000 | 7,853,000 | 6,991,000 | 9,418,000 | 9,139,000 | 6,353,000 | 7,711,000 | 5,607,000 | 3,518,000 | 5,834,000 | 7,796,000 | 5,639,000 | 4,694,000 |
| misc current assets | 3,283,000 | ||||||||||||||
| total current assets | 9,279,000 | 9,237,000 | 10,547,000 | 8,256,000 | 7,322,000 | 9,938,000 | 9,554,000 | 7,697,000 | 8,075,000 | 6,122,000 | 7,756,000 | 6,569,000 | 8,462,000 | 6,262,000 | 5,552,000 |
| total assets | 20,329,000 | 20,443,000 | 22,203,000 | 20,048,000 | 19,652,000 | 22,499,000 | 22,427,000 | 20,927,000 | 21,987,000 | 20,979,000 | 23,107,000 | 15,375,000 | 17,179,000 | 15,492,000 | 15,242,000 |
| Bank overdraft | 5,000 | 41,000 | |||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 419,000 | 290,000 | 503,000 | 42,000 | 406,000 | 563,000 | 379,000 | 254,000 | 280,000 | 408,000 | 598,000 | 326,000 | 393,000 | 34,000 | 685,000 |
| Group/Directors Accounts | |||||||||||||||
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | 6,470,000 | 5,487,000 | 6,231,000 | 3,685,000 | 2,389,000 | 5,729,000 | 5,559,000 | 4,271,000 | 5,038,000 | 4,428,000 | 5,017,000 | 3,602,000 | 5,341,000 | 4,801,000 | 3,873,000 |
| total current liabilities | 6,889,000 | 5,777,000 | 6,734,000 | 3,727,000 | 2,795,000 | 6,292,000 | 5,938,000 | 4,525,000 | 5,318,000 | 4,836,000 | 5,615,000 | 3,928,000 | 5,734,000 | 4,840,000 | 4,599,000 |
| loans | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | 259,000 | 10,000 | 49,000 | 560,000 | 1,370,000 | ||||||||||
| other liabilities | |||||||||||||||
| provisions | 196,000 | 249,000 | 240,000 | 308,000 | 267,000 | 441,000 | 505,000 | 485,000 | 481,000 | 336,000 | 146,000 | 148,000 | 845,000 | 906,000 | 1,152,000 |
| total long term liabilities | 455,000 | 259,000 | 289,000 | 868,000 | 1,637,000 | 441,000 | 505,000 | 485,000 | 481,000 | 336,000 | 146,000 | 148,000 | 845,000 | 906,000 | 1,152,000 |
| total liabilities | 7,344,000 | 6,036,000 | 7,023,000 | 4,595,000 | 4,432,000 | 6,733,000 | 6,443,000 | 5,010,000 | 5,799,000 | 5,172,000 | 5,761,000 | 4,076,000 | 6,579,000 | 5,746,000 | 5,751,000 |
| net assets | 12,985,000 | 14,407,000 | 15,180,000 | 15,453,000 | 15,220,000 | 15,766,000 | 15,984,000 | 15,917,000 | 16,188,000 | 15,807,000 | 17,346,000 | 11,299,000 | 10,600,000 | 9,746,000 | 9,491,000 |
| total shareholders funds | 12,985,000 | 14,407,000 | 15,180,000 | 15,453,000 | 15,220,000 | 15,766,000 | 15,984,000 | 15,917,000 | 16,188,000 | 15,807,000 | 17,346,000 | 11,299,000 | 10,600,000 | 9,746,000 | 9,491,000 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 6,002,000 | ||||||||||||||
| Depreciation | 649,000 | 615,000 | 593,000 | 706,000 | 715,000 | 706,000 | 770,000 | 814,000 | 825,000 | 828,000 | 611,000 | 432,000 | 583,000 | 609,000 | 700,000 |
| Amortisation | |||||||||||||||
| Tax | |||||||||||||||
| Stock | 4,000 | 1,000 | 53,000 | -25,000 | 13,000 | 1,000 | -2,000 | 12,000 | -1,000 | -15,000 | 2,000 | -16,000 | 6,000 | -36,000 | 104,000 |
| Debtors | 466,000 | -102,000 | 73,000 | 97,000 | -202,000 | 104,000 | -927,000 | 968,000 | -150,000 | -425,000 | 218,000 | 85,000 | 37,000 | -199,000 | 754,000 |
| Creditors | 129,000 | -213,000 | 461,000 | -364,000 | -157,000 | 184,000 | 125,000 | -26,000 | -128,000 | -190,000 | 272,000 | -67,000 | 359,000 | -651,000 | 685,000 |
| Accruals and Deferred Income | 1,232,000 | -783,000 | 2,035,000 | 486,000 | -1,970,000 | 170,000 | 1,288,000 | -767,000 | 610,000 | -589,000 | 1,415,000 | -1,739,000 | 540,000 | 928,000 | 3,873,000 |
| Deferred Taxes & Provisions | -53,000 | 9,000 | -68,000 | 41,000 | -174,000 | -64,000 | 20,000 | 4,000 | 145,000 | 190,000 | -2,000 | -697,000 | -61,000 | -246,000 | 1,152,000 |
| Cash flow from operations | 8,078,000 | ||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | -7,156,000 | -521,000 | -70,000 | -162,000 | -636,000 | ||||||||||
| Change in Investments | -21,000 | 523,000 | |||||||||||||
| cash flow from investments | 21,000 | -523,000 | -7,156,000 | -521,000 | -70,000 | -162,000 | -636,000 | ||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | |||||||||||||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | |||||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | 20,000 | 45,000 | -142,000 | -79,000 | -87,000 | -71,000 | |||||||||
| cash flow from financing | -1,000 | -140,000 | 45,000 | -142,000 | -79,000 | -87,000 | 9,237,000 | ||||||||
| cash and cash equivalents | |||||||||||||||
| cash | -428,000 | -1,209,000 | 2,165,000 | 862,000 | -2,427,000 | 279,000 | 2,786,000 | -1,358,000 | 2,104,000 | 2,089,000 | -2,316,000 | -1,962,000 | 2,157,000 | 945,000 | 4,694,000 |
| overdraft | -5,000 | -36,000 | 41,000 | ||||||||||||
| change in cash | -428,000 | -1,209,000 | 2,165,000 | 862,000 | -2,427,000 | 279,000 | 2,786,000 | -1,358,000 | 2,104,000 | 2,089,000 | -2,316,000 | -1,962,000 | 2,162,000 | 981,000 | 4,653,000 |
theatre royal (plymouth) limited Credit Report and Business Information
Theatre Royal (plymouth) Limited Competitor Analysis
Perform a competitor analysis for theatre royal (plymouth) limited by selecting its closest rivals, whether from the ARTS, ENTERTAINMENT AND RECREATION sector, other mid companies, companies in PL1 area or any other competitors across 12 key performance metrics.
theatre royal (plymouth) limited Ownership
THEATRE ROYAL (PLYMOUTH) LIMITED group structure
Theatre Royal (Plymouth) Limited has 1 subsidiary company.
Ultimate parent company
THEATRE ROYAL (PLYMOUTH) LIMITED
01560651
1 subsidiary
theatre royal (plymouth) limited directors
Theatre Royal (Plymouth) Limited currently has 15 directors. The longest serving directors include Mrs Bronwen Lacey (Sep 2012) and Mr James Pidgeon (Jul 2017).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mrs Bronwen Lacey | 69 years | Sep 2012 | - | Director | |
| Mr James Pidgeon | England | 37 years | Jul 2017 | - | Director |
| Mrs Shona Godefroy | 54 years | Sep 2018 | - | Director | |
| Mrs Sarah Fysh | 47 years | Sep 2018 | - | Director | |
| Mrs Emma-Marie Huxham | 45 years | Feb 2020 | - | Director | |
| Mrs Hannah Sloggett | 46 years | Nov 2022 | - | Director | |
| Mr Alastair Coomer | 49 years | Nov 2022 | - | Director | |
| Miss Samra Said | 42 years | Nov 2022 | - | Director | |
| Ms Sarah McAdam | 53 years | Nov 2022 | - | Director | |
| Mr Andrew Ibbs | 59 years | Nov 2022 | - | Director |
P&L
March 2024turnover
17.4m
+4%
operating profit
-1.9m
0%
gross margin
31.2%
-4.77%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
13m
-0.1%
total assets
20.3m
-0.01%
cash
8.4m
-0.05%
net assets
Total assets minus all liabilities
theatre royal (plymouth) limited company details
company number
01560651
Type
Private Ltd By Guarantee w/o Share Cap
industry
90010 - Performing arts
incorporation date
May 1981
age
44
incorporated
UK
ultimate parent company
accounts
Group
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
BISHOP FLEMING LLP
address
theatre royal, royal parade, plymouth, devon, PL1 2TR
Bank
NATIONAL WESTMINSTER BANK PLC
Legal Advisor
WOMBLE BOND DICKINSON
theatre royal (plymouth) limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 4 charges/mortgages relating to theatre royal (plymouth) limited. Currently there are 4 open charges and 0 have been satisfied in the past.
theatre royal (plymouth) limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for THEATRE ROYAL (PLYMOUTH) LIMITED. This can take several minutes, an email will notify you when this has completed.
theatre royal (plymouth) limited Companies House Filings - See Documents
| date | description | view/download |
|---|
